Edition:
United Kingdom

Julie Steenhuysen

Biogen builds case for its Alzheimer's drug, skeptics say more data needed

05 Dec 2019

SAN DIEGO/CHICAGO Biogen Inc on Thursday laid out more data on its experimental Alzheimer's drug that raised no major safety alarms but also offered little compelling evidence the drug, once declared a failure, actually works.

UPDATE 3-New Biogen data showed no major safety issues for its Alzheimer's drug

05 Dec 2019

SAN DIEGO/CHICAGO, Dec 5 Biogen Inc on Thursday presented new data on its experimental Alzheimer's drug aducanumab that eased concerns raised by some experts but still left many questions unanswered as the company made its case about why it plans to seek U.S. approval after declaring the drug a failure in March.

Biogen to make case to skeptics for its controversial Alzheimer's drug

05 Dec 2019

SAN DIEGO, Dec 5 Biogen Inc, looking to win over skeptics and health regulators, later on Thursday will present highly anticipated data on its experimental Alzheimer's drug aducanumab, which the U.S. biotech company had declared a failure earlier this year.

Treating HIV-infected infants very early substantially improves health: study

27 Nov 2019

CHICAGO A small study of African infants infected with HIV found that treating them with powerful drugs within the first hours and days of birth helped preserve their immune systems, improving their chances of better long-term health, U.S. researchers said on Wednesday.

New Roche flu drug can drive resistance in influenza viruses: researchers

25 Nov 2019

CHICAGO Roche's influenza treatment Xofluza, a one-dose pill that can clear flu symptoms within days, may cause a mutation of the virus that leads to drug resistance, researchers reported on Monday.

Longer-term data fail to clear concern over Takeda's dengue vaccine

23 Nov 2019

CHICAGO An additional six months of data from a late-stage trial of Takeda Pharmaceutical Co's experimental dengue vaccine again showed it failed to protect against one of the four types of the virus in an important patient group, researchers said on Saturday.

Canadian teen developed 'popcorn lung' type injury from vaping: report

21 Nov 2019

Researchers in Canada have identified a new kind of vaping-related lung injury they believe is linked to flavorings in conventional vape pens, causing symptoms similar to the "popcorn lung" injury seen in workers exposed to flavorings in microwave popcorn.

Influential U.S. doctors group calls for ban on vaping products

20 Nov 2019

CHICAGO The American Medical Association (AMA) on Tuesday called for a total ban on all e-cigarette and vaping products that are not approved by the U.S. Food and Drug Administration as smoking cessation tools.

Influential U.S. doctors group calls for ban on vaping products

19 Nov 2019

CHICAGO, Nov 19 The American Medical Association (AMA) on Tuesday called for a total ban on all e-cigarette and vaping products that are not approved by the U.S. Food and Drug Administration as smoking cessation tools.

World News